Drug discovery team with extensive expertise in Pharma R&D.
Fully integrated research functions across the whole discovery value chain.
Broad coverage for indications / disease areas including focus on Oncology.
Molecule research with strong foothold for small molecules with access to a high quality compound library.
Dedicated site across all research functions with fit-for-purpose infrastructure and state-of-the-art laboratory equipment.
Experienced leadership team comprising former global Pharma top discovery research executives.
Headcount: 459 employees (32% university graduates)
Lab Facilities: 25.000 m²
Office Facilities: 7.300 m²
Inspections & Authorizations
All permits for chemical and biological laboratories including S1/S2 levels, biosafety, radio protection, permits for in-vivo studies and experiments, handing of controlled substances, waste management etc.
Regular inspections by governmental authorities
The campus in the heart of Berlin’s city has a long tradition of a chemical and pharmaceutical R&D.
The campus was founded more than 150 years ago by Schering and it was expanded over the years. Since 2007 it is part of Bayer. Since 2020 NUVISAN is a significant tenant on the campus.
Working Fields & Specialties
NUVISAN’s research center comes with capabilities and capacities spanning the entire drug discovery value chain from target discovery to preclinical candidate, including